Navigation Links
Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound
Date:10/1/2008

ective clinical trial participants should refer to the informed consent document.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com. P-LLY

This press release contains forward-looking statements about the potential of the investigational compound LY450139 and reflects Lilly's current beliefs. However, as with any pharmaceutical product under development, there are substantial risks and uncertainties in the process of development and regulatory review. There is no guarantee that the product will receive regulatory approvals, or that the regulatory approval will be for the indication(s) anticipated by the company. There is also no guarantee that the product will prove to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filing with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

(1) Alzheimer's Association. "2008 Alzheimer's Disease Facts and Figures." Available at: http://www.alz.org/national/documents/report_alzfactsfigures2008.pdf. Accessed September 22, 2008.

(2) Small, GW, Rabins, PV, Barry, PP, Buckholtz, NS, DeKosky, ST, Ferris, SH, Finkel, SI, Gwyther, LP, Khachaturian, ZS, Lebowitz, BD, McRae, TD, Morris, JC, Oakley, F, Schneider, LS, Streim, JE, Sunderland, T, Teri, LA, Tune, LE. Diagnosis and Treatment of Al
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... Insulin Pump, today reported its financial results for the quarter ... second quarter of 2014 to the same period of 2013: ... $5.5 million , t:slim Pump shipments grew 64 percent ... six months ended June 30, 2014 to the same period ...
(Date:7/31/2014)... Calif. , July 31, 2014  Alexza ... provided an update on its pipeline and new ... Alexza expects to initiate a Phase 2a study ... being developed for the management of patients with ... new Staccato -based product candidates for development ...
(Date:7/31/2014)... July 31, 2014  Decision Resources Group is launching ... product Marketrack to now include ChinaTrack; the new capabilities ... in an interactive dashboard providing detailed brand-level share tracking ... a hospital level. Other key capabilities of ... feed: In addition to end-user surveys of healthcare facilities, ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Decision Resources Group Announces First Medical Device Account Targeting Tool in China 2
... TUCSON, Ariz., Feb. 4 Aung FootHealth Clinics ... recruiting patients with,lower extremity diabetic foot ulcers to ... will study the effects of Excellarate(TM) (GAM501),(Ad5PDGF-B/bovine Type ... with neuropathic non-healing diabetic foot ulcers. Excellarate is,an ...
... Inc. (OTC,Bulletin Board: GOVX), http://www.geovax.com, an ... co-founder Dr. Harriet Robinson,to its staff as Vice ... worldwide for her outstanding work on retrovirus biology ... HIV/AIDS., Significant advances by GeoVax,s HIV/AIDS vaccine ...
Cached Medicine Technology:Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial 2Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program 2Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program 3Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program 4
(Date:8/1/2014)... “When insulation goes bad,” Clean Crawls says, ... a newly released article entitled, “ 5 Signs That ... Replaced ,” Clean Crawls explains the need to replace ... by critters. , Get a free attic insulation ... http://www.cleancrawl.com/contact . , If crawl space or attic ...
(Date:8/1/2014)... Seattle, Wa (PRWEB) August 01, 2014 According ... Vkool.com, this is a comprehensive diet guide for women who ... discover a list of protein rich foods and ... keeping lean muscle mass. , Vkool writes in its review ... to readers the truth about fat burning hormones and weight ...
(Date:8/1/2014)... La Coste, TX (PRWEB) August 01, 2014 ... 3 organization dedicated to serving patients, caregivers and families affected ... appointment of Sharon Kramer Sutton of La Coste, TX to ... for her husband of 39 years, Eric Sutton. He was ... Nov 11, 2013 at home with his family. Like many ...
(Date:8/1/2014)... Blindness is a reversible ailment these ... of today, despite well-meaning efforts, still have a long way ... for reversing blindness that does not involve any kind of ... alternative medicine takes the “slack” from the mainstream by providing ... harmful surgeries. , Alternative health specialist Kevin Richardson actually ...
(Date:8/1/2014)... August 01, 2014 Narrow networks ... plans and employers effective options to trim pharmacy ... argue that they can enhance formulary compliance and ... Consultants report that nearly all PBMs now include ... for proposals. The Aug. 12 webinar from ...
Breaking Medicine News(10 mins):Health News:5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls 2Health News:The Metabolic Switch Diet PDF Review Exposes Sally Asher's Diet Guide For Boosting Metabolism – Vkool.com 2Health News:The Metabolic Switch Diet PDF Review Exposes Sally Asher's Diet Guide For Boosting Metabolism – Vkool.com 3Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Sharon Kramer Sutton, 30 Year Veteran of Rare Disease Advocacy, Appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:The Miracle Cure Review | The Unbeatable Secret to Reversing Any Vision Problem – Vinamy.com 2Health News:Atlantic Information Services Webinar to Offer Health Plan, Employer Strategies for Implementing Narrow Pharma Networks 2
... VA Decreased muscle strength is associated with ... crouching, or kneeling (SCK) in older adults, according ... issue of Physical Therapy (PTJ), the ... (APTA). These researchers found that adults with SCK ...
... differ from each other in many ways, and they can ... to resist a host of weapons fired at them. ... One potential weapon is a small-molecule "broad ... attacking them through some feature common to an entire class ...
... “Aligning ... the way employees engage inside and outside of the workplace. , ... Milwaukee, Wisc. (PRWEB) February 1, 2010 -- 7Summits’ CEO, ... and Personal Brand,” hosted by Loyola University in Chicago. The hands-on workshop kicks ...
... People underestimate effect on heart from androgen deprivation, ... -- Men with prostate cancer and the physicians ... androgen-deprivation therapy (ADT) commonly used against the malignancy ... cardiac death. , "There is a substantial amount ...
... , PHILADELPHIA , Feb. ... plc will announce its full year financial results for the year ... announcement will be released to the London Stock Exchange at approximately ... www.gsk.com . , Following the announcement, Andrew Witty , Chief ...
... , Rare, but serious, liver disorder reported in ... The U.S. Food and Drug Administration today announced that non-cirrhotic ... reported in some HIV patients taking Videx/Videx EC (didanosine). ... antiretroviral medicine first approved by the FDA in 1991. Videx ...
Cached Medicine News:Health News:Decreased muscle strength predicts functional impairments in older adults 2Health News:Decreased muscle strength predicts functional impairments in older adults 3Health News:Researchers find 'broad spectrum' antiviral that fights multitude of viruses 2Health News:Researchers find 'broad spectrum' antiviral that fights multitude of viruses 3Health News:7Summits to Present at Soho Seminars 'Alignment of Personal and Corporate Brands' 2Health News:Experts Issue Warning on Prostate Hormone Therapy 2Health News:Experts Issue Warning on Prostate Hormone Therapy 3Health News:GSK 2009 Financial Results Announcement and Teleconference Details 2Health News:FDA Announces Safety Risk Associated with HIV Drug 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: